Shares decline around 2 per cent as a US securities fraud class-action lawsuit and uncertainty over MD & CEO Sashidhar Jagdishan’s succession weigh on sentiment
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.